Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy

Retina

Volumn 22, Issue 5, 2002, Pages 545-549

  Spaide, Richard F ^a   Freund, K Bailey ^a   Slakter, Jason ^a   Sorenson, John ^a   Yannuzzi, Lawrence A ^a   Fisher, Yale ^a  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

Choroidal neovascularization; Multifocal choroiditis and panuveitis; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHOROIDITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HUMAN; PHOTODYNAMIC THERAPY; RISK BENEFIT ANALYSIS; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 0036796143     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200210000-00003     Document Type: Article

References (23)

1. Dreyer RF, Gass DJ. Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis. Arch Ophthalmol 1984;102:1776-1784.
2. Morgan CM, Schatz H. Recurrent multifocal choroiditis. Ophthalmology 1986;93:1138-1147.
3. Slakter JS, Giovannini A, Yannuzzi LA, et al. Indocyanine green angiography of multifocal choroiditis. Ophthalmology 1997;104:1813-1819.
4. Reddy CV, Brown J Jr, Folk JC, et al. Enlarged blind spots in chorioretinal inflammatory disorders. Ophthalmology 1996; 103:606-617.
5. Brown J Jr, Folk JC, Reddy CV, Kimura AE. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996;103:1100-1105.
6. Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisation in young patients. Eye 1998;12:266-272.
7. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol 1999:117:1329-1345.
8. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
9. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-336.
10. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-1396.
11. Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 1995;15:198-205.
12. Eckstein M, Wells JA. Aylward B, Gregor Z. Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye 1998;12:775-780.
13. Brindeau C, Glacet-Bernard A, Coscas F, et al, Surgical removal of subfoveal choroidal neovascularization: visual outcome and prognostic value of fluorescein angiography and optical coherence tomography. Eur J Ophthalmol 2001;11:287-295.
14. Yazawa M, Isomae T, Mori R, Shimade H, Utsunomiya I. Surgical excision versus laser photocoagulation for subfoveal choroidal neovascularization membranes with age-related macular degeneration: comparison of visual outcomes. Jpn J Ophthalmol 2001;45:192-198.
15. Thomas MA, Grand MG, Williams DF, et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-968.
16. Gass JDM. Biomicroscopical and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994;118:285-298.
17. Merill PT, LoRusso FJ, Lomeo MD, et al. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology 1999;106:782-789.
18. Fujii GY, Pieramici DJ, Humayun MS, et al, Complications associated with limited macular translocation. Am J Ophthalmol 2000:130:751-762.
19. Fujii GY, Humayun MS, Pieramici DJ, et al. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration. Am J Ophthalmol 2001;131:90-100.
20. Reichel E, Berrocal AM, Ip M, et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999;106:1908-1914.
21. Spaide RF, Guyer DR, McCormick B, et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30.
22. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration. Ophthalmology 1999;106:2239-2247.
23. Marcus D, Sheils W, Johnson M, et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Arch Ophthalmol 2001;119:171-180.